13910C>T and 22018G>A LCT gene polymorphisms in diagnosing hypolactasia in children

J Tomczonek-Moruś1, A Wojtasik1, K Zeman1

  • 1Department of Paediatrics, Immunology and Nephrology, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland.

Insights

Genetic testing for LCT gene polymorphisms can diagnose primary lactose intolerance in children over six years old. This method shows a significant correlation with hydrogen breath test results in this age group.

Area of Science:

  • Genetics
  • Pediatrics
  • Gastroenterology

Background:

  • Primary lactose intolerance (PLI) involves a gradual decrease in lactase activity, typically emerging between ages 1-5 years.
  • PLI is genetically linked to specific single-nucleotide polymorphisms (SNPs) in the lactase (LCT) gene.

Purpose of the Study:

  • To evaluate the utility of genetic testing for LCT gene polymorphisms (13910C>T and 22018G>A) in diagnosing lactose intolerance in children.
  • To determine the correlation between LCT gene polymorphisms and hydrogen breath test (HBT) results in pediatric patients.

Main Methods:

  • A study involving 99 children (2 months to 16.5 years) with various digestive symptoms.
  • Hydrogen breath test (HBT) and blood sample collection for LCT polymorphism analysis were performed on all participants.
  • PLI was defined by the presence of 13910CC and/or 22018GG polymorphisms alongside a positive HBT result.

Main Results:

  • In children under 6 years, no significant correlation was found between LCT polymorphisms (13910CC and/or 22018GG) and HBT results.
  • A statistically significant correlation was observed in children older than 6 years between the 13910CC (p=0.0011) and 22018GG (p=0.003) LCT polymorphisms and HBT results.

Conclusions:

  • Genetic testing for LCT 13910C>T and 22018G>A polymorphisms can aid in diagnosing lactose intolerance in children over six years of age.
  • The diagnostic utility of these genetic markers is age-dependent, showing significance in older children but not in those under six.
Abstract

Related Concept Videos

Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.0K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
685
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
160
Gene Flow02:39

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
37.6K